title: Glutamate enhances phosphorylation of neurofilaments in cerebellar granule cell culture.
abstract: In amyotrophic lateral sclerosis (ALS), an abnormal increase of glutamate in the central nervous system indicates that it may play a key role in motor neuron death. The neuronal accumulation of phosphorylated neurofilaments (NFs) suggests an alteration of phosphorylation of NFs is also involved. Rat cerebellar granule cells (CGCs) are sensitive to glutamate neurotoxicity and provide a suitable model system for clarifying its mechanisms. Using cultured CGCs, we investigated the relationship between glutamate neurotoxicity and the phosphorylation of NFs. Because glutamate showed a dose-dependent neurotoxicity for CGCs, we adopted a 10 microM glutamate treatment, which produced no acute neurotoxicity during the experiments. The number of phosphorylated heavy subunits of neurofilaments (NF-Hs) increased to approximately twice that of the control after 72 h, although the total number of NF-Hs remained constant throughout the experiment. The phosphorylation of NF-Hs was significantly suppressed by the AMPA-receptor antagonist CNQX, but not by the NMDA-receptor antagonist MK-801. Our findings therefore suggest that exposure to a low concentration of glutamate enhances the phosphorylation of NF-Hs, mainly via the AMPA receptor.
authors.affiliation: Department of Neurology, Neurological Institute, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, Japan. asahara@neuro.med.kyushu-u.ac.jp
authors.forename: H
authors.initials: H
authors.lastname: Asahara
authors.forename: T
authors.initials: T
authors.lastname: Taniwaki
authors.forename: Y
authors.initials: Y
authors.lastname: Ohyagi
authors.forename: T
authors.initials: T
authors.lastname: Yamada
authors.forename: J
authors.initials: J
authors.lastname: Kira
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000209:etiology / Q000503:physiopathology; D000818:Animals; D000831:Animals, Newborn; D018929:Cell Culture Techniques; D002531:Cerebellum / Q000378:metabolism*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018698:Glutamic Acid / Q000494:pharmacology*; D016900:Neurofilament Proteins / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism*; D010766:Phosphorylation; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D018691:Excitatory Amino Acid Antagonists; D016900:Neurofilament Proteins; D018698:Glutamic Acid